HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C L Silva Selected Research

Mycobacterium heat-shock protein 65

9/2004Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C L Silva Research Topics

Disease

15Tuberculosis (Tuberculoses)
12/2012 - 02/2000
13Infections
08/2011 - 02/2000
6Inflammation (Inflammations)
06/2021 - 02/2005
4Asthma (Bronchial Asthma)
06/2021 - 07/2010
4Hypersensitivity (Allergy)
09/2015 - 10/2008
3Neoplasms (Cancer)
12/2011 - 10/2008
2Pulmonary Eosinophilia (Eosinophilic Pneumonia)
06/2021 - 01/2012
2Pulmonary Tuberculosis
08/2011 - 09/2004
1Respiratory Hypersensitivity
09/2015
1Eosinophilia
09/2015
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2013
1Weight Gain
09/2013
1Fungal Lung Diseases
02/2013
1Paracoccidioidomycosis (South American Blastomycosis)
02/2013
1Mycoses (Diseases, Fungus)
02/2013
1Lymphoma (Lymphomas)
12/2011
1Rheumatoid Arthritis
07/2010
1Periodontal Diseases (Periodontal Disease)
07/2010
1Communicable Diseases (Infectious Diseases)
07/2010
1Pneumonia (Pneumonitis)
12/2009
1Edema (Dropsy)
10/2008
1Pain (Aches)
10/2008
1Squamous Cell Carcinoma of Head and Neck
10/2008
1Lung Injury
09/2004
1HIV Infections (HIV Infection)
01/2003

Drug/Important Bio-Agent (IBA)

8VaccinesIBA
07/2010 - 06/2000
7Heat-Shock Proteins (Heat-Shock Protein)IBA
06/2021 - 04/2003
5CytokinesIBA
09/2015 - 09/2001
5DNA VaccinesIBA
02/2013 - 02/2000
4AntigensIBA
03/2015 - 05/2001
4DNA (Deoxyribonucleic Acid)IBA
01/2012 - 02/2000
4A-Form DNA (A-DNA)IBA
07/2009 - 12/2003
2OvalbuminIBA
06/2021 - 09/2015
2Therapeutic UsesIBA
06/2021 - 09/2004
2AllergensIBA
03/2015 - 01/2012
2Interleukin-10 (Interleukin 10)IBA
01/2012 - 12/2001
2Biomarkers (Surrogate Marker)IBA
12/2011 - 01/2003
2LeukotrienesIBA
08/2011 - 07/2010
2Integrin alpha4beta1 (VLA-4)IBA
08/2002 - 12/2001
1Immunoglobulin E (IgE)IBA
06/2021
1Proteins (Proteins, Gene)FDA Link
09/2015
1Dermatophagoides pteronyssinus antigen p 1IBA
03/2015
1OligodeoxyribonucleotidesIBA
03/2015
1BCG VaccineFDA Link
09/2013
1Streptozocin (Streptozotocin)FDA Link
09/2013
1Liposomes (Liposome)IBA
02/2013
1Messenger RNA (mRNA)IBA
12/2012
1Recombinant DNA (Recombinant DNA Research)IBA
01/2012
1anisole (anisol)IBA
12/2011
14-cymene (p-cymene)IBA
12/2011
1Tumor Biomarkers (Tumor Markers)IBA
12/2011
1ProstaglandinsIBA
08/2011
1Biological ProductsIBA
08/2011
1Interleukin-5 (Interleukin 5)IBA
04/2011
1Interleukin-17 (Interleukin 17)IBA
07/2010
1Histidine DecarboxylaseIBA
12/2009
1Histamine (Histamine Dihydrochloride)FDA Link
12/2009
1EnzymesIBA
12/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2009
1Interleukin-6 (Interleukin 6)IBA
12/2009
1Pharmaceutical PreparationsIBA
02/2005
1Mycobacterium heat-shock protein 65IBA
09/2004
1Interferon-gamma (Interferon, gamma)IBA
09/2004
1adhesion receptorIBA
08/2002
1InterferonsIBA
12/2001
1InterleukinsIBA
12/2001
1Interleukin-12 (IL 12)IBA
12/2001
1Cell Surface ReceptorsIBA
12/2001
1TrehaloseIBA
09/2001

Therapy/Procedure

7Immunotherapy
06/2021 - 12/2001
2Therapeutics
09/2004 - 01/2003
1Oral Administration
06/2021
1Aftercare (After-Treatment)
10/2008
1Drug Therapy (Chemotherapy)
02/2005
1Duration of Therapy
02/2005